Nxera Pharma Co Ltd (SOLTF)
8.052
0.00 (0.00%)
USD |
OTCM |
Nov 14, 16:00
Nxera Pharma Max Drawdown (5Y): 95.29% for Sept. 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2024 | 95.29% |
| August 31, 2024 | 95.29% |
| July 31, 2024 | 95.29% |
| June 30, 2024 | 95.29% |
| May 31, 2024 | 95.29% |
| April 30, 2024 | 95.29% |
| March 31, 2024 | 95.29% |
| February 29, 2024 | 95.29% |
| January 31, 2024 | 95.29% |
| December 31, 2023 | 95.29% |
| November 30, 2023 | 95.86% |
| October 31, 2023 | 95.86% |
| September 30, 2023 | 95.86% |
| August 31, 2023 | 96.61% |
| July 31, 2023 | 96.61% |
| June 30, 2023 | 96.61% |
| May 31, 2023 | 96.61% |
| April 30, 2023 | 96.61% |
| March 31, 2023 | 96.61% |
| February 28, 2023 | 96.61% |
| January 31, 2023 | 96.61% |
| December 31, 2022 | 96.61% |
| November 30, 2022 | 96.61% |
| October 31, 2022 | 96.61% |
| September 30, 2022 | 96.61% |
| Date | Value |
|---|---|
| August 31, 2022 | 96.61% |
| July 31, 2022 | 96.61% |
| June 30, 2022 | 96.61% |
| May 31, 2022 | 96.61% |
| April 30, 2022 | 96.61% |
| March 31, 2022 | 96.61% |
| February 28, 2022 | 96.61% |
| January 31, 2022 | 96.61% |
| December 31, 2021 | 96.61% |
| November 30, 2021 | 96.61% |
| October 31, 2021 | 96.61% |
| September 30, 2021 | 96.61% |
| August 31, 2021 | 96.61% |
| July 31, 2021 | 96.61% |
| June 30, 2021 | 96.61% |
| May 31, 2021 | 96.61% |
| April 30, 2021 | 96.61% |
| March 31, 2021 | 96.61% |
| February 28, 2021 | 96.61% |
| January 31, 2021 | 96.61% |
| December 31, 2020 | 96.61% |
| November 30, 2020 | 96.61% |
| October 31, 2020 | 96.61% |
| September 30, 2020 | 96.61% |
| August 31, 2020 | 96.61% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
95.29%
Minimum
Dec 2023
96.61%
Maximum
Nov 2019
96.35%
Average
96.61%
Median
Nov 2019
Max Drawdown (5Y) Benchmarks
| Takeda Pharmaceutical Co Ltd | 54.24% |
| PeptiDream Inc | 87.73% |
| Healios KK | -- |
| AnGes Inc | -- |
| SanBio Co Ltd | 95.95% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -23.39 |
| Beta (5Y) | 0.2802 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 56.43% |
| Historical Sharpe Ratio (5Y) | -0.3466 |
| Historical Sortino (5Y) | -0.5107 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 27.70% |